To further confirm the role of RHOA in CM prognosis, KM analysis indicated that the expression of RHOA was significantly negatively connected with the overall survival (OS) of CM patients in both TCGA and GSE65904 cohorts. This evidence concerns the gene RHOA and cutaneous mastocytosis.